莱涅佐利德诱导的后部可逆脑病综合征:一个病例报告和文献综述
Jamir Pitton Rissardo1, Priya Shah2, Kaitlyn Piotrowski2
1Neurology Department, Cooper University Hospital.
Clinical neuropharmacology
|March 10, 2026
概括
莱涅佐利德很少会导致后部可逆脑病综合征 (PRES),这是一种影响大脑的疾病. 这一案例突出了潜在的出血并发症和linezolid诱导的PRES的延迟恢复.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 后部可逆脑病综合征 (PRES) 是一种神经疾病,其特征是血管性,精神状态变化,,头痛和视觉障碍.
- PRES通常与高血压,细胞毒药物和自身免疫性疾病有关.
研究的目的:
- 报告一种罕见的PRES病例,可能是由linezolid治疗引起的.
- 为了突出潜在的出血并发症和延迟的恢复与线索利德诱导的PRES相关.
主要方法:
- 一个77岁的女性患者的病例报告,在开始治疗血后进行了linezolid治疗后发展了PRES.
- 使用了神经学检查,EEG,MRI和文献审查.
- 终止了linezolid的治疗,并对患者的结果进行了监测.
主要成果:
- 患者在开始服用linezolid后48小时内出现精神状态变化和呼吸困扰.
- 核磁共振扫描显示了带有PRES特征的下关节和膜内出血.
- 文献审查发现了另外两例与线化物相关的PRES,但没有出血并发症.
结论:
- 莱涅佐利德诱导的PRES是一种罕见但显著的临床事件.
- 这个病例表明了潜在的出血并发症和延长的恢复期.
- 早期识别和及时管理因线化物诱导的PRES至关重要.
关键词:
在这里,我们可以看到 PRESES.药物不良反应 药物不良反应抗生素 抗生素是一种抗生素.药物诱导的神经毒性药物诱导的神经毒性在线zolidlid是什么意思磁共振成像技术的使用后部可逆脑病症综合征 后部可逆脑病症综合征更多相关视频
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
12.0K
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.7K
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
